VASCULAR EXPRESSION OF PVEGFR2 IN PEDIATRIC PILOCYTIC ASTROCYTOMA SUGGESTS THERAPEUTIC POTENTIAL AS A TARGET FOR ANTI-ANGIOGENIC TREATMENT STRATEGIES

被引：0
|
作者：
Sikkema, A. H. [1 ]
de Bont, E. S. J. M. [1 ]
Molema, G. [2 ]
Dimberg, A. [3 ]
Zwiers, P. J. [2 ]
Diks, S. H. [1 ]
Hoving, E. W. [4 ]
Kamps, W. A. [1 ]
Peppelenbosch, M. P. [5 ]
den Dunnen, W. F. A.
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, NL-9713 AV Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands
[3] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, NL-9713 AV Groningen, Netherlands
[5] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
来源：
NEURO-ONCOLOGY | 2010年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：II93 / II93
页数：1
相关论文
共 30 条
  • [1] Overlapping high pro- and anti-angiogenic VEGF-A isoform ratio between pediatric pilocytic astrocytoma and adult glioblastoma suggests possibilities for anti-angiogenic therapy in pilocytic astrocytoma
    Sie, Mariska
    den Dunnen, Wilfred F. A.
    Scherpen, Frank J. G.
    Hoving, Eelco W.
    de Bont, Eveline S. J. M.
    CANCER RESEARCH, 2012, 72
  • [2] Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer
    Brock, CS
    Lee, SM
    EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (03) : 557 - 570
  • [3] Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategies
    Kessler, TA
    Pfeifer, A
    Silletti, S
    Mesters, RM
    Berdel, WE
    Verma, I
    Cheresh, D
    ANNALS OF HEMATOLOGY, 2002, 81 : S69 - S70
  • [4] IKKβ is a potential anti-angiogenic therapeutic target in KRAS-induced lung cancer
    Lobo, Tatiana C.
    Magalhaes, Leila
    Cardeal, Laura
    Giordano, Ricardo
    Baldwin, Albert
    Basseres, Daniela
    CANCER RESEARCH, 2015, 75
  • [5] Capillary morphogenesis gene 2 is a potential target for anti-angiogenic therapy
    Ye, L.
    Mason, M.
    Jiang, W. G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S163 - S164
  • [6] Changes in Vascular Permeability and Expression of Different Angiogenic Factors Following Anti-Angiogenic Treatment in Rat Glioma
    Ali, Meser M.
    Janic, Branislava
    Babajani-Feremi, Abbas
    Varma, Nadimpalli R. S.
    Iskander, A. S. M.
    Anagli, John
    Arbab, Ali S.
    PLOS ONE, 2010, 5 (01):
  • [7] Dynamic FLT PET for Investigating Potential Synergistic Therapeutic Targets During Anti-Angiogenic Treatment
    Scarpelli, M.
    Simoncic, U.
    Perlman, S.
    Liu, G.
    Jeraj, R.
    MEDICAL PHYSICS, 2016, 43 (06) : 3691 - 3692
  • [8] Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review
    Al-Abd, Ahmed M.
    Alamoudi, Abdulmohsin J.
    Abdel-Naim, Ashraf B.
    Neamatallah, Thikryat A.
    Ashour, Osama M.
    JOURNAL OF ADVANCED RESEARCH, 2017, 8 (06) : 591 - 605
  • [9] IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target
    Carneiro-Lobo, Tatiana Correa
    Scalabrini, Luiza Coimbra
    Magalhaes, Leila da Silva
    Cardeal, Laura B.
    Rodrigues, Felipe Silva
    dos Santos, Edmilson Ozorio
    Baldwin, Albert S.
    Levantini, Elena
    Giordano, Ricardo J.
    Basseres, Daniela Sanchez
    LUNG CANCER, 2019, 130 : 169 - 178
  • [10] Heme oxygenase 1 (HO-1): An auspicious target for state of the art anti-angiogenic therapeutic strategies and new insights in prostate carcinogenesis
    Gueron, Geraldine
    Ferrando, Mercedes
    Elguero, Belen
    Giudice, Jimena
    Salles, Angeles
    Labanca, Estefania
    Jaworsky, Felipe
    Colombo, Lucas
    Meiss, Roberto
    Navone, Nora
    De Siervi, Adriana
    Vazquez, Elba
    CANCER RESEARCH, 2012, 72
123